- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06042205
TISSIUM™ Adhesive Hernia Repair System (TAHRS) Pilot Study
March 20, 2024 updated by: Tissium
ALPHA: A Pilot Study to Evaluate the Initial Safety and Performance of the TISSIUM™ Adhesive Hernia Repair System (TAHRS) for Atraumatic Laparoscopic Hernia Repair
The purpose of this study is to capture preliminary clinical safety and performance on the TAHRS
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sr. Manager, Clinical Affairs
- Phone Number: +1 857-408-0709
- Email: ntrinward@tissium.com
Study Locations
-
-
-
Bonheiden, Belgium
- Recruiting
- Imelda Hospital
-
Principal Investigator:
- Tollens
-
Ruddershove, Belgium
- Active, not recruiting
- AZ Sint-Jan
-
-
Limburg
-
Genk, Limburg, Belgium, 3600
- Recruiting
- Ziekenhuis Oost-Limburg [ZOL]
-
Principal Investigator:
- Kurt Van Der Speeten
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Key Inclusion Criteria:
- Subject is 18 years old or older;
- Patient willing and able to provide a signed Patient Informed Consent Form;
- Has a midline primary ventral, umbilical or incisional hernia;
- Scheduled for a laparoscopic IPOM hernia repair;
- Hernia can be successfully repaired with at least a 5 cm overlap of the mesh on all sides of the defect
Key Exclusion Criteria:
- Patient has a known or suspected hypersensitivity to the constituent polymer of the investigational device, mesh, or other surgical products (e.g., sutures);
- BMI > 40;
- Patient is a current smoker, defined as self-reporting smoking more than 1 cigarette per day;
- Patient is taking systemic immunosuppressive medications, systemic steroids, or chemotherapy at the time of informed consent;
- Patient is pregnant, plans to become pregnant during the study period, or is breastfeeding;
- Patient with Type 1 or uncontrolled Type 2 Diabetes Mellitus;
- Patient has more than one hernia defect (to be confirmed intraoperatively);
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Hernia repair
There is no comparator for this study.
All patients are in the treatment allocated group for hernia repair with TISSIUM™ Adhesive Hernia Repair System (TAHRS)
|
The TAHRS is intended for fixation of prosthetic material to soft tissue
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serious Adverse Device Effect (SADEs)
Time Frame: through 12 months post-surgery
|
Cumulative incidence of complications (CIC) related to the TAHRS including: Infection, Chronic pain, Recurrence of hernia, Impaired/delayed healing at the surgical site(s), Allergic reaction/hypersensitivity reaction, |
through 12 months post-surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Rate of hernia recurrence through 12 months post- surgery
Time Frame: through 12 months post-surgery
|
through 12 months post-surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 4, 2023
Primary Completion (Estimated)
March 28, 2025
Study Completion (Estimated)
March 28, 2025
Study Registration Dates
First Submitted
September 8, 2023
First Submitted That Met QC Criteria
September 14, 2023
First Posted (Actual)
September 18, 2023
Study Record Updates
Last Update Posted (Actual)
March 21, 2024
Last Update Submitted That Met QC Criteria
March 20, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PF00006-CLPR-002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hernia
-
University of NebraskaLifeCellCompletedHiatal Hernia | Esophageal Hernia | Hernia, Esophageal | Hernia, Paraesophageal | Paraesophageal Hiatal Hernia | Sliding Esophageal Hernia | Sliding Hiatal HerniaUnited States
-
Medtronic - MITGCompletedInguinal Hernia | Ventral HerniaUnited States
-
Mette Astrup MadsenCompletedInguinal Hernia | Femoral HerniaDenmark
-
Advanced Medical Solutions Ltd.CompletedInguinal Hernia | Hernia | Femoral Hernia | Groin HerniaUnited States
-
W.L.Gore & AssociatesRecruitingHernia, Hiatal | Hernia, Diaphragmatic | Hernia, Ventral | Incisional HerniaUnited States
-
Hobart HarrisWithdrawnHernia | Ventral Hernia | Abdominal Hernia
-
Foregut Research FoundationNot yet recruitingParaesophageal Hernia | Large Hiatal HerniaUnited States
-
Konya Meram State HospitalCompletedInguinal Hernia | Ventral Hernia | General SurgeryTurkey
-
Zealand University HospitalCompletedInguinal Hernia | Femoral HerniaDenmark
-
Anne Arundel Health System Research InstituteMedtronic - MITGCompletedGrade I Ventral Hernia | Grade II Ventral HerniaUnited States
Clinical Trials on TISSIUM™ Adhesive Hernia Repair System (TAHRS)
-
San Bonifacio HospitalCompletedIndirect Inguinal Hernia | Direct Inguinal HerniaItaly
-
Cook Group IncorporatedCompleted
-
Insightra Medical, Inc.Completed
-
Intuitive SurgicalRecruiting
-
Intuitive SurgicalRecruitingVentral HerniaUnited States
-
Helsinki University Central HospitalCompleted
-
Intuitive SurgicalRecruitingVentral HerniaUnited States
-
The Cleveland ClinicIntuitive SurgicalCompleted
-
Quanta MedicalCousin BiotechCompleted
-
The University of Texas Health Science Center,...Withdrawn